1. New Zealand Stocks

  2. •

    Health technology

  3. •

    Biotechnology
Promisia Healthcare Limited

Promisia Healthcare Limited

NNZX:PHL
0.67
NZD
0.00
(0.00%)
0.21EPS
1.92P/E
24.78MMarket Cap
2012 Y
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2022 Y
2023 Y
2024 Y
2025 Y
2026 Y
Revenue per Share
0.03
0.09
0.11
0.24
1.15
0.92
0.39
0.04
0.43
0.53
0.56
0.58
0.72
Basic EPS, GAAP
-0.28
-0.34
-0.42
-0.57
-0.2
-0.34
-1.5
-0.56
0.05
0.01
0.04
0.13
0.25
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
-0.9
-0.5
-0.03
0.23
0.68
0.4
0.26
-0.31
0.45
0.49
0.67
0.75
1.05
Tangible Book Value per Share
-0.9
-0.5
-0.08
0.14
0.58
0.35
0.25
-0.31
0.45
0.49
0.67
0.75
1.05
Basic Weighted Avg Shares
1
2
2
2
2
3
1
4
43
42
43
51
53
Sales/Revenue/Turnover
- -
- -
- -
- -
3
2
1
- -
18
22
24
30
38
Operating Margin (%)
-882.35
-316.87
-328.57
-221.08
-15.2
-38.98
-421.74
-702.26
10.06
5.46
3.02
3.72
9.58
Depreciation Expense
- -
- -
- -
- -
- -
- -
- -
- -
1
1
1
- -
1
Net Income, GAAP
- -
-1
-1
-1
- -
-1
-2
-2
2
1
2
7
13
Effective Tax Rate (%)
- -
- -
- -
- -
- -
- -
- -
- -
19.21
- -
54.56
1.6
7.3
Profit Margin (%)
-1,082.35
-360
-381.57
-234.8
-17.37
-36.84
-384.87
-1,351.41
12.26
2.75
6.76
23.02
34.14
Working Capital
-1
- -
- -
2
3
1
2
-1
-19
-60
-79
-87
-140
LT Debt
1
1
1
1
1
- -
1
1
16
19
5
40
- -
Total Equity
-1
-1
- -
1
2
1
1
-1
19
21
29
39
55
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
5.56
- -
0.24
0.45
1.91
Return on Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
13.53
- -
2.87
7.36
9.37
Return on Common Equity (%)
- -
- -
- -
- -
-41.71
-63.25
-219.54
- -
- -
3.1
6.63
20.13
27.36

Capital Structure

NZD

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

NZD

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

NZD

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
-248.67%
-276.66%
40.56%
Free Cash Flow
- -
- -
- -
Net Income, GAAP
52.37%
61.68%
89.04%
Sales/Revenue/Turnover
1,068.99%
2,041.14%
27.5%
Total Cash Common Dividend
- -
- -
- -

Semi-annual Revenue

NZD

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
24
2025
- -
- -
30
2026
- -
- -
38

Semi-annual Earnings Per Share

NZD

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
0.04
2025
- -
- -
0.13
2026
- -
- -
0.25

Semi-annual Dividends Per Share

NZD

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
- -
2025
- -
- -
- -
2026
- -
- -
- -

Company Description

Company Profile APIChatGPT
CEO
Peter Meintjes
Full Time Employees
467
Sector
Health technology
Industry
Biotechnology
Address
50 Customhouse Quay Wellington Central WGN New Zealand 6011
IPO Date
Jun 16, 1986
Website
promisia.com
Similar Companies
Moderna, Inc. (NASDAQ:MRNA)
Amgen Inc. (NASDAQ:AMGN)
Iovance Biotherapeutics, Inc. (NASDAQ:IOVA)
Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX)
Novavax, Inc. (NASDAQ:NVAX)
10x Genomics, Inc. (NASDAQ:TXG)
Business
Promisia Healthcare Limited operates within New Zealand's aged care and retirement living sector. The company provides a range of residential options, encompassing independent living villas and apartments, alongside comprehensive care services. These services include rest home, hospital, and specialised care for dementia, respite, palliative needs, and younger individuals with disabilities. Promisia Healthcare currently manages a portfolio of three retirement villages and two residential care facilities, offering a total of 401 care beds, 76 care suites or apartments, and 156 villas. This entity, which was formerly known as Promisia Integrative Limited, adopted its current name in February 2021. Established in 1983, Promisia Healthcare Limited maintains its headquarters in Wellington, New Zealand.